Literature DB >> 27770590

Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications.

Y H Cho1,2, M E Craig1,2,3, A S Januszewski4, P Benitez-Aguirre1,2, S Hing1, A J Jenkins4, K C Donaghue1,2.   

Abstract

AIM: To test the hypothesis that non-invasive skin autofluorescence, a measure of advanced glycation end products, would provide a surrogate measure of long-term glycaemia and be associated with early markers of microvascular complications in adolescents with Type 1 diabetes.
METHODS: Forearm skin autofluorescence (arbitrary units) was measured in a cross-sectional study of 135 adolescents with Type 1 diabetes [mean ± sd age 15.6 ± 2.1 years, diabetes duration 8.7 ± 3.5 years, HbA1c 72 ± 16 mmol/mol (8.7 ± 1.5%)]. Retinopathy, assessed using seven-field stereoscopic fundal photography, was defined as ≥1 microaneurysm or haemorrhage. Cardiac autonomic function was measured by standard deviation of consecutive RR intervals on a 10-min continuous electrocardiogram recording, as a measure of heart rate variability.
RESULTS: Skin autofluorescence was significantly associated with age (R2 = 0.15; P < 0.001). Age- and gender-adjusted skin autofluorescence was associated with concurrent HbA1c (R2 = 0.32; P < 0.001) and HbA1c over the previous 2.5-10 years (R2 = 0.34-0.43; P < 0.002). Age- and gender-adjusted mean skin autofluorescence was higher in adolescents with retinopathy vs those without retinopathy [mean 1.38 (95% CI 1.29, 1.48) vs 1.22 (95% CI 1.17, 1.26) arbitrary units; P = 0.002]. In multivariable analysis, retinopathy was significantly associated with skin autofluorescence, adjusted for duration (R2 = 0.19; P = 0.03). Cardiac autonomic dysfunction was also independently associated with skin autofluorescence (R2 = 0.11; P = 0.006).
CONCLUSIONS: Higher skin autofluorescence is associated with retinopathy and cardiac autonomic dysfunction in adolescents with Type 1 diabetes. The relationship between skin autofluorescence and previous glycaemia may provide insight into metabolic memory. Longitudinal studies will determine the utility of skin autofluorescence as a non-invasive screening tool to predict future microvascular complications.
© 2016 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27770590     DOI: 10.1111/dme.13280

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

1.  Skin autofluorescence is associated with inappropriate left ventricular mass and diastolic dysfunction in subjects at risk for cardiovascular disease.

Authors:  Chun-Cheng Wang; Yao-Chang Wang; Guei-Jane Wang; Ming-Yi Shen; Yen-Lin Chang; Show-Yih Liou; Hung-Chih Chen; An-Sheng Lee; Kuan-Cheng Chang; Wei-Yu Chen; Chiz-Tzung Chang
Journal:  Cardiovasc Diabetol       Date:  2017-01-25       Impact factor: 9.951

2.  Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.

Authors:  C Blanc-Bisson; F L Velayoudom-Cephise; A Cougnard-Gregoire; C Helmer; K Rajaobelina; C Delcourt; L Alexandre; L Blanco; K Mohammedi; M Monlun; V Rigalleau
Journal:  Cardiovasc Diabetol       Date:  2018-06-08       Impact factor: 9.951

3.  Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis.

Authors:  Mahboobeh Sadat Hosseini; Zahra Razavi; Amir Houshang Ehsani; Alireza Firooz; Siamack Afazeli
Journal:  EClinicalMedicine       Date:  2021-11-16

4.  Advanced Glycation End Products Are Associated with Diabetes Status and Physical Functions in Patients with Cardiovascular Disease.

Authors:  Tomoya Hirai; Kazuhiro Fujiyoshi; Satoru Yamada; Takuya Matsumoto; Junko Kikuchi; Kohki Ishida; Miwa Ishida; Minako Yamaoka-Tojo; Takayuki Inomata; Kyo Shigeta; Taiki Tojo
Journal:  Nutrients       Date:  2022-07-24       Impact factor: 6.706

5.  The Bright Side of Skin Autofluorescence Determination in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Potential Predictor of Remission?

Authors:  Kristina Podolakova; Lubomir Barak; Emilia Jancova; Juraj Stanik; Katarina Sebekova; Ludmila Podracka
Journal:  Int J Environ Res Public Health       Date:  2022-09-21       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.